712
Participants
Start Date
October 23, 2013
Primary Completion Date
November 22, 2016
Study Completion Date
May 29, 2017
Ranibizumab
0.5 mg intravitreal injection
Aflibercept
2 mg intravitreal injection
Novartis Investigative Site, Laken
Novartis Investigative Site, Vienna
Novartis Investigative Site, Geneva
Novartis Investigative Site, Fribourg
Novartis Investigative Site, Glostrup Municipality
Novartis Investigative Site, Leuven
Novartis Investigative Site, Bern
Novartis Investigative Site, Roskilde
Novartis Investigative Site, Arendal
Novartis Investigative Site, Salzburg
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Dijon
Novartis Investigative Site, Kiel
Novartis Investigative Site, Bremen
Novartis Investigative Site, Marburg
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Wolfsburg
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Essen
Novartis Investigative Site, Mülheim
Novartis Investigative Site, Münster
Novartis Investigative Site, Münster
Novartis Investigative Site, Bad Rothenfelde
Novartis Investigative Site, Cologne
Novartis Investigative Site, Cologne
Novartis Investigative Site, Bonn
Novartis Investigative Site, Siegburg
Novartis Investigative Site, Mainz
Novartis Investigative Site, Hagen
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Darmstadt
Novartis Investigative Site, Sulzbach
Novartis Investigative Site, Homburg
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Västerås
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, München
Novartis Investigative Site, Ulm
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Créteil
Novartis Investigative Site, Bayreuth
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Braga
Novartis Investigative Site, Feldkirch
Novartis Investigative Site, Graz
Novartis Investigative Site, Linz
Novartis Investigative Site, Vienna
Novartis Investigative Site, Paris
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Glauchau
Novartis Investigative Site, Leipzig
Novartis Investigative Site, 's-Hertogenbosch
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Nijmegen
Novartis Investigative Site, Oslo
Novartis Investigative Site, Coimbra
Novartis Investigative Site, Coimbra
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Porto
Novartis Investigative Site, Porto
Novartis Investigative Site, Vila Franca de Xira
Novartis Investigative Site, Vila Nova de Gaia
Novartis Investigative Site, Stockholm
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY